Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate CancerDavid Lorente, Johann S. de Bono, George Seed et al.|European Urology|2016Cited by 154
Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC countsDavid Lorente, Johann S. de Bono, David Olmos et al.|Annals of Oncology|2018Cited by 97